Increased IDO Expression and Regulatory T Cells in Acute Myeloid Leukemia
Author Information
Author(s): Hakak Raziyeh, Poopak Behzad, Majd Ahmad
Primary Institution: Department of Cellular and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Azad University, Tehran, Iran
Hypothesis
This study aimed to determine the frequency of regulatory T cells (Tregs) and indoleamine 2,3-dioxygenase (IDO) expression in patients with acute myeloid leukemia (AML).
Conclusion
IDO inhibition using novel IDO inhibitors along with chemotherapy is a promising approach to overcome the immune escape mechanisms in patients with AML.
Supporting Evidence
- The Treg percentage among total lymphocytes was lower in the AML group than in the normal group.
- The mean IDO expression in the AML group was significantly higher than that in the normal group.
- A significant relationship was observed between IDO expression and Treg percentage among Th lymphocytes in the AML group.
- Western blot analysis showed a significant increase in IDO protein intensity in the AML group compared with the control group.
- A significant difference was observed between TGF-β levels in the AML group and those in the control group.
Takeaway
This study found that patients with acute myeloid leukemia have higher levels of certain immune cells and proteins that help cancer cells avoid the immune system, suggesting new treatment strategies.
Methodology
This cross-sectional case–control study collected bone marrow samples from 20 healthy individuals and 15 patients with AML, using flow cytometry, real-time PCR, and western blotting to evaluate Treg and IDO expression levels.
Limitations
The study had a small sample size and incomplete data for some patients, limiting the ability to assess clinical outcomes.
Participant Demographics
Among the 15 patients with AML, 4 (26.7%) were male and 11 (73.3%) were female; the normal group had 13 males and 7 females.
Statistical Information
P-Value
p=0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website